Saturday 17 October 2026
Export BAX’s income statement to Excel — free account
Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
25.33
0.43
−1.67%
Follow BAX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(4.50%) | (14.58%) | (16.80%) | (15.78%) | |
Piotroski F-Score |
4 | 4 | 3 | 3 | |
| (1.43%) | (4.18%) | (5.34%) | (5.21%) | ||
ROIC |
(0.06%) | (1.41%) | (1.39%) | (1.27%) | |
Return on Tangible Assets |
(5.71%) | (14.05%) | (18.10%) | (16.84%) | |
Average Days of Receivables |
58.84 | 60.41 | 54.75 | 59.06 | |
Free Cash Flow per Share |
0.47 | 0.65 | 1.40 | 1.58 | |
Free Cash Flow |
244.00 | 332.00 | 723.00 | 815.00 | |
Capital Expenditures |
(505.00) | (513.00) | (528.00) | (504.00) | |
| Other line items | |||||
Cash ROIC |
1.32% | 1.89% | 4.13% | 4.58% | |
Accounts Receivable Turnover |
6.29 | 6.35 | 6.77 | 6.32 | |
Accounts Payable Turnover |
8.10 | 8.00 | 7.72 | 7.91 | |
Inventory Turnover |
3.18 | 3.68 | 3.53 | 3.45 | |
Average Days of Payables |
47.90 | 46.36 | 50.11 | 47.06 | |
Days of Inventory on Hand |
123.64 | 103.58 | 106.86 | 102.81 | |
Tax Rate |
0.31 | 0.78 | 0.93 | 1.00 | |
Research and Development Expense of Revenue |
5.47% | 4.61% | 4.57% | 4.46% | |
Selling, General and Administrative Expense of Revenue |
26.22% | 25.70% | 25.75% | 25.56% | |
Share Based Compensation of Revenue |
1.08% | 1.04% | 1.03% | 1.00% | |
Interest Coverage |
(0.05) | (1.29) | (1.25) | (1.11) | |
Operating CF/Net income |
(2.20) | (0.88) | (1.14) | (1.24) | |
Depreciation/Fixed assets |
0.52 | 0.60 | 0.60 | 0.59 | |
Capex/Depreciation |
(0.35) | (0.29) | (0.30) | (0.29) | |
Revenue per Share |
21.45 | 21.92 | 21.98 | 22.19 | |
Operating CF per Share |
1.46 | 1.65 | 2.43 | 2.55 | |
Capex per Share |
(0.98) | (1.00) | (1.03) | (0.97) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 |
Columns are period end dates